Trademark: Neuracthelle 2297512
Word
Neuracthelle
ID
2297512
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
07 April 2022
Registration Date
07 April 2022
Renewal Date
07 April 2032
Owner(s)
Service
Goods and Services:
Class 3:
Non-medicated cosmetics; cosmetics for protecting against light and UV; cosmetics, namely cosmetic products as leave-on, lotions, cremes, ointments and other formulations as well as cosmetic products for topical use; non-medicated preparations for protecting the skin against light and UV; non-medicated skin photoprotection preparations; sun care preparations for cosmetic use; sun-tanning preparations (cosmetics); suntan lotions (cosmetics); suntan oils (cosmetics); tanning gels (cosmetics); cosmetic preparations for skin care containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic preparations for tanning the skin without sunlight containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun protection preparations; cosmetic preparations for protecting the skin from the sun's rays; cosmetics for protecting the skin from sunburn; sun protecting creams (cosmetics); sun barriers (cosmetics); sun block (cosmetics); sun blocking preparations (cosmetics); sun-block lotions; sun blocking oils (cosmetics); SPF sun block sprays; sun protectors for lips; sun blocking lipsticks (cosmetics); sunscreens; waterproof sunscreen; water-resistant sunscreen; sunscreen preparations; sunscreen creams; sunscreen lotions; sunscreen sticks; cosmetic foams containing sunscreens; preparations for protecting the hair from the sun; non-medicated preparations for the relief of sunburn; non-medicated compounds for skin care after exposure to the sun's rays.
Non-medicated cosmetics; cosmetics for protecting against light and UV; cosmetics, namely cosmetic products as leave-on, lotions, cremes, ointments and other formulations as well as cosmetic products for topical use; non-medicated preparations for protecting the skin against light and UV; non-medicated skin photoprotection preparations; sun care preparations for cosmetic use; sun-tanning preparations (cosmetics); suntan lotions (cosmetics); suntan oils (cosmetics); tanning gels (cosmetics); cosmetic preparations for skin care containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic preparations for tanning the skin without sunlight containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun protection preparations; cosmetic preparations for protecting the skin from the sun's rays; cosmetics for protecting the skin from sunburn; sun protecting creams (cosmetics); sun barriers (cosmetics); sun block (cosmetics); sun blocking preparations (cosmetics); sun-block lotions; sun blocking oils (cosmetics); SPF sun block sprays; sun protectors for lips; sun blocking lipsticks (cosmetics); sunscreens; waterproof sunscreen; water-resistant sunscreen; sunscreen preparations; sunscreen creams; sunscreen lotions; sunscreen sticks; cosmetic foams containing sunscreens; preparations for protecting the hair from the sun; non-medicated preparations for the relief of sunburn; non-medicated compounds for skin care after exposure to the sun's rays.
Class 5:
Pharmaceuticals; pharmaceutical drugs; pharmaceutical products for endocrine, neuroendocrine, systemic, inflammatory, and acute disorders such as sepsis, shock, haemorrhagic shock, acute bleeding disorders, and chronic disorders requiring prevention, curative or palliative treatment where no other treatments are effective or safe; pharmaceutical preparations; pharmaceuticals used for cerebrovascular accidents (strokes); pharmaceutical preparations for the prevention and treatment of arterial ischemic strokes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases; cardiovascular drugs for use in treating hypertension; cardiovascular preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; cardiovascular agents for medical purposes; cardiovascular drugs used in treating shocks; cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; cardiovascular drugs used in treating congestive heart failure (CHF); pharmaceutical preparations containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for medical purposes which contain analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; afamelanotide aqueous and gel formulations; pharmaceutical implants; subcutaneous implants containing afamelanotide; implantable medicines; implantable medicines containing afamelanotide.
Pharmaceuticals; pharmaceutical drugs; pharmaceutical products for endocrine, neuroendocrine, systemic, inflammatory, and acute disorders such as sepsis, shock, haemorrhagic shock, acute bleeding disorders, and chronic disorders requiring prevention, curative or palliative treatment where no other treatments are effective or safe; pharmaceutical preparations; pharmaceuticals used for cerebrovascular accidents (strokes); pharmaceutical preparations for the prevention and treatment of arterial ischemic strokes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases; cardiovascular drugs for use in treating hypertension; cardiovascular preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; cardiovascular agents for medical purposes; cardiovascular drugs used in treating shocks; cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; cardiovascular drugs used in treating congestive heart failure (CHF); pharmaceutical preparations containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for medical purposes which contain analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; afamelanotide aqueous and gel formulations; pharmaceutical implants; subcutaneous implants containing afamelanotide; implantable medicines; implantable medicines containing afamelanotide.
Class 10:
Medical apparatus, devices and instruments; apparatus for drug administration; devices for use in the administration of pharmaceuticals; controlled rate release apparatus for dispensing pharmaceutical substances; medical fluid injectors; injection syringes; medical syringes; implantable subcutaneous drug delivery devices.
Medical apparatus, devices and instruments; apparatus for drug administration; devices for use in the administration of pharmaceuticals; controlled rate release apparatus for dispensing pharmaceutical substances; medical fluid injectors; injection syringes; medical syringes; implantable subcutaneous drug delivery devices.